Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07369050 · ClinicalTrials.gov registry record · NA
A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses
A NA study, sponsored by M.D. Anderson Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 48
- Enrollment target
NCT07369050: Clinical Trial NA study, sponsored by M.D. Anderson Cancer Center.
NCT07369050 is a NA study that has not yet begun recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 48 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07369050, a NA study, has not yet begun recruiting, sponsored by M.D. Anderson Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn if regular use of Provox® ActiValve® by patients after a total laryngectomy with TEP can decrease the number of VP device replacements needed annually.
Interventions
- DEVICE Provox® ActiValve®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2030-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07369050
The ClinicalTrials.gov registry entry for NCT07369050 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Provox® ActiValve® is the first listed.
NCT07369050 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07369050 about?
NCT07369050 is a clinical study titled "A Randomized Trial Comparing Routine Use of the ActiValve to Standard Voice Prostheses". The goal of this clinical research study is to learn if regular use of Provox® ActiValve® by patients after a total laryngectomy with TEP can decrease the number of VP device replacements needed annually.
What is the current status of trial NCT07369050?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2026-07-01. Estimated completion is 2030-09-01.
What interventions are being tested in trial NCT07369050?
The interventions under investigation include: Provox® ActiValve® (DEVICE).
Who is sponsoring clinical trial NCT07369050?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.